-
Product Insights
Gleason Gas Turbine Power Plant
Gleason Gas Turbine Power Plant is a thermal project located in Tennessee, United States. The project is owned by Tennessee Valley Authority. The project came online in 2000. Empower your strategies with our Gleason Gas Turbine Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Company Profile
Hubbell Inc – Company Profile
Hubbell Inc (Hubbell) is an electrical and electronic products manufacturer. It designs, manufactures, and sells its products for a wide range of applications in non-residential and residential construction, industrial, energy-related markets and utility markets. The company's product portfolio includes ground fault devices, high voltage test systems, LED components, mechanical connectors, specialty lighting, pole line hardware, insulators, arresters, and others. It offers the products through electrical and industrial distributors, home centers, retail and hardware outlets, and lighting showrooms. The company markets...
Add to Basket -
Sector Analysis
EpiCast Report: Prostate Cancer – Epidemiology Forecast to 2026
Prostate cancer is a malignancy in the prostate gland, which is located below the bladder and in front of the rectum in males. Worldwide, about 1.1 million men were diagnosed with prostate cancer in 2012. Diagnosed incident cases of prostate cancer is defined as malignant neoplasms with the prostate gland as the primary site (ICD-10 code C61, ICD-O-3 code C61.9). The forecast relies on data from national cancer registries, peer-reviewed journal articles, and primary market research. CRPC was defined as...
-
Sector Analysis
Prostate Cancer – Global Drug Forecast and Market Analysis to 2028
The prostate cancer market in the 8 major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China) is expected to experience a moderate growth between 2018 and 2018. The main drivers of growth will be an aging population, continued uptake of second-generation hormonal agents in the metastatic hormone naïve (mHNPC) and non-metastatic castration resistant (nmCRPC) prostate cancer settings, and the launch and uptake of 13 new premium-priced therapies, including the newly approved Nubeqa (darolutamide). Until recently, the hormone...
-
Sector Analysis
Prostate Cancer – Epidemiology Forecast to 2028
Prostate cancer is a malignancy in the prostate gland, which is located below the bladder and in front of the rectum in males. Worldwide, about 1.2 million men were diagnosed with prostate cancer in 2018 (International Agency for Research on Cancer, 2019). Almost all prostate cancers are adenocarcinomas, a type of cancer that develops in gland cells. Most prostate cancers are asymptomatic and grow very slowly. In advanced stages of prostate cancer, the malignancy has spread to other organs such...